About: Sunnybrook Research Institute

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Sunnybrook Research Institute Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

the research component of Sunnybrook Health Sciences Centre in Toronto, Canada

Attributes	Values
rdf:type	Item
owl:sameAs	Sunnybrook Research Institute
description	institut de recherche au Canada (fr) Forschungseinrichtung in Kanada (de) the research component of Sunnybrook Health Sciences Centre in Toronto, Canada (en)
rdfs:label	Sunnybrook Research Institute (en)
skos:prefLabel	Sunnybrook Research Institute (en)
name	Sunnybrook Research Institute (en)
Freebase ID	wds:Q7640792-18090bd9-476b-ac5b-ae6d-17e598b528d7
Freebase ID	/m/05p48_r
ROR ID	wds:Q7640792-5F39626C-615C-40FD-8436-5547037D3CBA
ROR ID	05n0tzs53
instance of	wds:Q7640792-788cf4f0-41df-ccf6-0a21-f91829ecc8e3
part of	wds:Q7640792-8ee2f82d-40a2-faca-0002-83c63fceb93b
instance of	research institute
part of	Sunnybrook Health Sciences Centre
country	wds:Q7640792-393a463b-4a26-deee-6913-4e5113b23c34
country	Malawi
Open Funder Registry funder ID	wds:Q7640792-096D395A-67B9-4AF2-812D-8CF9FD8EAABD
Ringgold ID	wds:Q7640792-DB532287-0265-44DF-8216-FD0F5C67136B
Open Funder Registry funder ID	100011021
Ringgold ID	282299
headquarters location	wds:Q7640792-82C1FABC-1768-424A-B75C-A731B3EE297C
headquarters location	Toronto
skos:altLabel	sunnybrook.ca/research (en)
ISNI	wds:Q7640792-8C529DD0-B182-4314-A439-1E643B1AD5A8
Quora topic ID	wds:Q7640792-8AF282D9-EE67-44EF-AD16-49915003C5C5
member of	wds:Q7640792-1183C5E5-358B-4AC3-ABC8-598C9BCE5079
Microsoft Academic ID	wds:Q7640792-4E4C5B9F-0F4A-4E45-A79E-0EC77C09CF92
Microsoft Academic ID	https://makg.org/entity/203763938
ISNI	0000000404691398
Quora topic ID	Sunnybrook-Research-Institute
member of	Digital Research Alliance of Canada
Microsoft Academic ID	203763938
is about of	Sunnybrook Research Institute https://www.wikidata.org/wiki/Special:EntityData/Q7640792 Sunnybrook Research Institute
is research site of	A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200) Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). Pembrolizumab + Epacadostat vs Pembrolizumab + Placebo in Recurrent or Progressive Metastatic Urothelial Carcinoma Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer Safety and Efficacy of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension The Sunnybrook Type 2 Diabetes Study Study of Zevalin Versus Observation in Patients at Least 60 Yrs Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in PET-negative Complete Remission After R-CHOP or R-CHOP-like Therapy Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304) PROPEL Randomized Trial A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC HEMOglobin Transfusion Threshold in Traumatic Brain Injury OptimizatioN: The HEMOTION Trial Primary Radiotherapy Versus Primary Surgery for HPV-Associated Oropharyngeal Cancer A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Patients With High-Risk Muscle-Invasive Bladder Cancer Who Are ctDNA Positive Following Cystectomy Cervical Ca PROs in Clinical Practice Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3) RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy BREVITY A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101) A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2) Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors Physiological Magnetic Resonance Imaging (MRI) to Improve Carotid Endarterectomy Outcomes Predicting Emergency Department Delirium With an Interactive Customizable Tablet to Prevent Repeat Visits The Metformin Active Surveillance Trial (MAST) Study Fixation Using Alternative Implants for the Treatment of Hip Fractures (FAITH-2) NOn-invasive Repeated THerapeutic STimulation for Aphasia Recovery A Study of Renal Denervation in Patients With Treatment Resistant Hypertension RCT Meropenem vs Piperacillin-Tazobactam for Definitive Treatment of BSI's Due to Ceftriaxone Non-susceptible Escherichia Coli and Klebsiella Spp.
is research site of	wds:Q63578653-EE7A0868-F815-44F7-9D35-F818B76B191F wds:Q63591022-00360456-844C-4FCF-8154-389ADF704013 wds:Q64805813-C909AC9A-1F2E-4136-8340-F57D3C693FDB wds:Q64647657-6E340DEE-A220-4643-8E28-93CBB108F498 wds:Q64351385-B0DDBBEA-2C87-43D2-B048-5064425F3B7B wds:Q65351952-63911B08-664D-4523-AB88-38B22D3179CA wds:Q61956233-EA23C8C6-DCF6-469B-84D9-5CA3090685D8 wds:Q64172768-A77DE86F-0D84-4443-A575-42B603477C0A wds:Q97461684-4666D922-0AF0-45DB-960C-9024FA8B249C wds:Q64807799-57101E70-5F49-4AEB-9FA5-EF0ED6F4215A wds:Q66078517-CB3F6001-0748-4ADA-88DE-184C541FAE1C wds:Q64173227-9BBF5BC0-0EDD-4CD4-AEF2-9CAE1B54E1A5 wds:Q64397189-4A42AF89-70F3-4ED6-8767-58E8E43E1DE1 wds:Q64836787-FDA24F0C-3787-4804-A288-DE76ED60408E wds:Q64189658-071D4230-0466-4AC8-AD45-A8B7C3E0E1A8 wds:Q105788695-2DF1D781-2D65-4D5B-8167-FD713446F2A6 wds:Q63813120-38AE2EEE-A689-4598-8C80-F927EB4FCBD9 wds:Q64354793-6E9CAA52-A851-4484-AA7E-239A08138D4C wds:Q64801639-28D49D43-D593-414E-B9F8-2C8EF0CFC9DA wds:Q64173392-4A86BA28-776B-4EB8-A570-88AB1F9B95E8 wds:Q64139647-0F92218C-0267-4CE5-87F2-DB2517720C32 wds:Q63815584-498B9A89-F197-4896-B5EA-AC038C48AA67 wds:Q64791989-48FB368C-BD93-4DB2-868F-648B3F460036 wds:Q64803275-0AE55903-61F9-4000-8B38-BF71E50590CA wds:Q65365632-F51D482F-4F2C-4B27-A077-7D215A0893EA wds:Q64622441-F47F59CD-8557-4131-B950-90E39B87C018 wds:Q64350334-3174BF97-B7FE-4CB2-A436-86859F6B06C3 wds:Q65363638-C5A1CFC6-E793-4E0C-A812-7D74AFCB7E11 wds:Q64611307-B6962114-8C03-4CC2-BDF3-026A3AB942A4
is employer of	Jessica Widdifield Laura M Vecchio Michele K. Anderson Taku Hibino David William Andrews

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software